| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.094 | 0.4 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |